Identification and Characterization of Persistent Human Erythrovirus Infection in Blood Donor Samples
Open Access
- 15 November 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (22) , 12169-12178
- https://doi.org/10.1128/jvi.78.22.12169-12178.2004
Abstract
The presence of human erythrovirus DNA in 2,440 blood donations from the United Kingdom and sub-Saharan Africa (Ghana, Malawi, and South Africa) was screened. Sensitive qualitative and real-time quantitative PCR assays revealed a higher prevalence of persistent infection with the simultaneous presence of immunoglobulin G (IgG) and viral DNA (0.55 to 1.3%) than previously reported. This condition was characterized by a low viral load (median, 558 IU/ml; range, 42 to 135,000 IU/ml), antibody-complexed virus, free specific IgG, and potentially infectious free virus. Human erythrovirus genotype 1 (formerly parvovirus B19) was prevalent in the United Kingdom, Malawi, and South Africa. In contrast, only human erythrovirus genotype 3 (erythrovirus variant V9) was prevalent in Ghana. Genotype 3 had considerable genetic diversity, clustering in two probable subtypes. Genotype 1-based antibody assays failed to detect 38.5% of Ghanaian samples containing antibodies to genotype 3 virus but did not fail to detect cases of persistent infection. This study indicates a potential African origin of genotype 3 human erythrovirus and considerable shortcomings in the tools currently used to diagnose erythrovirus infection.Keywords
This publication has 60 references indexed in Scilit:
- Detection and Differentiation of Human Parvovirus Variants by Commercial Quantitative Real-Time PCR TestsJournal of Clinical Microbiology, 2004
- Quantification of Parvovirus B19 DNA Using COBAS AmpliPrep Automated Sample Preparation and LightCycler Real-Time PCRThe Journal of Molecular Diagnostics, 2004
- Parvovirus B19 transmission by heat‐treated clotting factor concentratesTransfusion, 2002
- Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: High prevalence of HIV-1 subtype C and of markers of hepatitis B and C virusesJournal of Medical Virology, 2001
- Identification of an Immunodominant Peptide in the Parvovirus B19 VP1 Unique Region Able to Elicit a Long-Lasting Immune Response in HumansViral Immunology, 2001
- Large-Scale Screening for Human Parvovirus B19 DNA by PCR: Application to the Quality Control of Plasma for FractionationVox Sanguinis, 2000
- Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion RecipientsVox Sanguinis, 1998
- Diary of EventsVox Sanguinis, 1998
- Epitope Type-Specific IgG Responses to Capsid Proteins VP1 and VP2 of Human Parvovirus B19The Journal of Infectious Diseases, 1995
- The prevalence of antibody to human parvovirus B 19 in England and WalesJournal of Medical Microbiology, 1988